Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-19-009407
Filing Date
2019-06-18
Accepted
2019-06-18 18:57:23
Documents
1
Period of Report
2019-06-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5085
  Complete submission text file 0001493152-19-009407.txt   7134
Mailing Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10011
Business Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10011 646-597-6980
RTW INVESTMENTS, LP (Reporting) CIK: 0001493215 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38938 | Film No.: 19904768

Mailing Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10019
Business Address
WONG RODERICK (Reporting) CIK: 0001493280 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38938 | Film No.: 19904769

Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations